These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15602164)

  • 1. Cost of chronic hepatitis B infection in South Korea.
    Yang BM; Kim CH; Kim JY
    J Clin Gastroenterol; 2004; 38(10 Suppl 3):S153-7. PubMed ID: 15602164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of the societal costs of hepatitis B in South Korea.
    Yang BM; Paik SW; Hahn OS; Yi DH; Choi MS; Payne S
    J Gastroenterol Hepatol; 2001 Mar; 16(3):301-8. PubMed ID: 11339422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The societal burden of HBV-related disease: South Korea.
    Yang BM; Kim DJ; Byun KS; Kim HS; Park JW; Shin S
    Dig Dis Sci; 2010 Mar; 55(3):784-93. PubMed ID: 19333757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of chronic hepatitis B virus infection in Taiwan.
    Hsieh CR; Kuo CW
    J Clin Gastroenterol; 2004; 38(10 Suppl 3):S148-52. PubMed ID: 15602163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of chronic hepatitis B infection in China.
    Zhiqiang G; Zhaohui D; Qinhuan W; Dexian C; Yunyun F; Hongtao L; Iloeje UH
    J Clin Gastroenterol; 2004; 38(10 Suppl 3):S175-8. PubMed ID: 15602167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of chronic hepatitis B infection in the United States.
    Lee TA; Veenstra DL; Iloeje UH; Sullivan SD
    J Clin Gastroenterol; 2004; 38(10 Suppl 3):S144-7. PubMed ID: 15602162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B.
    Nguyen MH; Burak Ozbay A; Liou I; Meyer N; Gordon SC; Dusheiko G; Lim JK
    J Hepatol; 2019 Jan; 70(1):24-32. PubMed ID: 30287341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The direct cost of managing patients with chronic hepatitis B infection in Australia.
    Butler JR; Pianko S; Korda RJ; Nguyen S; Gow PJ; Roberts SK; Strasser SI; Sievert W
    J Clin Gastroenterol; 2004; 38(10 Suppl 3):S187-92. PubMed ID: 15602169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost comparison of management of chronic hepatitis B and its associated complications in Hong Kong and Singapore.
    Li SC; Ong SC; Lim SG; Yeoh KG; Kwong KS; Lee V; Lee W; Lau J; Wong I; Kung N; Leung WT; Chan HL; Chan FK; Sung JJ; Lee KK
    J Clin Gastroenterol; 2004; 38(10 Suppl 3):S136-43. PubMed ID: 15602161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment costs in Canada of health conditions resulting from chronic hepatitis B infection.
    Gagnon YM; Levy AR; Iloeje UH; Briggs AH
    J Clin Gastroenterol; 2004; 38(10 Suppl 3):S179-86. PubMed ID: 15602168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B management costs in France, Italy, Spain, and the United Kingdom.
    Brown RE; De Cock E; Colin X; Antoñanzas F; Iloeje UH
    J Clin Gastroenterol; 2004; 38(10 Suppl 3):S169-74. PubMed ID: 15602166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea].
    Kim BK; Kwon SY; Lee CH; Choe WH; Choi HM; Koo HW
    Korean J Hepatol; 2009 Mar; 15(1):25-41. PubMed ID: 19346783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population health impact and cost-effectiveness of monitoring inactive chronic hepatitis B and treating eligible patients in Shanghai, China.
    Toy M; Salomon JA; Jiang H; Gui H; Wang H; Wang J; Richardus JH; Xie Q
    Hepatology; 2014 Jul; 60(1):46-55. PubMed ID: 24990105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of total economic burden of chronic hepatitis B (CHB)-related diseases in Beijing and Guangzhou, China.
    Hu M; Chen W
    Value Health; 2009; 12 Suppl 3():S89-92. PubMed ID: 20586991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database].
    Lim SJ; Kim HJ; Nam CM; Chang HS; Jang YH; Kim S; Kang HY
    J Prev Med Public Health; 2009 Jul; 42(4):251-60. PubMed ID: 19675402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-World Epidemiology, Treatment Patterns, and Disease Burden of Chronic Hepatitis B and HDV Co-Infection in South Korea.
    Cho Y; Park S; Park S; Choi W; Kim B; Han H
    Infect Dis Ther; 2023 Oct; 12(10):2387-2403. PubMed ID: 37768482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare Costs for Acute Hospitalized and Chronic Heart Failure in South Korea: A Multi-Center Retrospective Cohort Study.
    Ku H; Chung WJ; Lee HY; Yoo BS; Choi JO; Han SW; Jang J; Lee EK; Kang SM
    Yonsei Med J; 2017 Sep; 58(5):944-953. PubMed ID: 28792137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Financial burden of hepatitis B-related diseases and factors influencing the costs in Shenzhen, China].
    Liang S; Zhang SX; Ma QS; Xiao HW; Lü QY; Xie X; Mei SJ; Hu DS; Zhou BP; Li B; Chen JF; Cui FQ; Wang FZ; Liang XF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1340-5. PubMed ID: 21223660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of antiviral prophylaxis during pregnancy for the prevention of perinatal hepatitis B infection in South Korea.
    Lee D; Shin HY; Park SM
    Cost Eff Resour Alloc; 2018; 16():6. PubMed ID: 29467596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.